As of December 31, 2013, California skilled nursing providers reduced the unnecessary use of off-label, antipsychotics by more than 18 percent, exceeding the national goal of a 15 percent reduction. Since then providers have achieved a total reduction of 34 percent. California now ranks 9th best in the nation in reducing these drugs.
2015 Antipsychotic Partnership Report
Background: In May, 2012, the Centers for Medicare and Medicaid Services (CMS) announced a "Partnership to Improve Dementia Care in Nursing Homes,” a public–private partnership to ensure appropriate care and use of off-label antipsychotic medication for nursing home patients.
This initiative continues to be promoted in California by a coalition of interested stakeholders including CAHF, California Department of Public Health Licensing and Certification, CMS Region IX, California Association of Long-Term Care Medicine, Health Services Advisory Group and others that are working together to plan strategies and share resources under the direction of the California Culture Change Coalition.
CAHF is encouraged by CMS’ call to facilitate the formation of a partnership in California to reduce the unnecessary use of antipsychotic medications in nursing homes and urges all California facilities to participate in the focused effort.